Jun 15, 2022 by Kody KesterIs This High-Yield Dividend Stock a Buy?Amid the broader market's sell-off, Prudential's dividend yield has swelled to a whopping 5.1%.
Jun 15, 2022 by Kody Kester3 Reasons to Buy This Blue Chip Healthcare StockEven in recessions, healthcare is an exceptionally resilient industry.
Jun 15, 2022 by Kody KesterShould You Build Your Portfolio Around This Home Improvement Dividend Stock?Home Depot is the most dominant home improvement retailer in the world.
Jun 15, 2022 by Kody KesterLooking for Passive Income? Buy This Dividend KingThis company has raised its payout for 52 years straight and at the current share price offers a market-trouncing 7.6% yield.
Jun 14, 2022 by Kody Kester2 Best Dividend Stocks That Wall Street Is Sleeping OnThese two financial stocks pay market-topping dividends to shareholders.
Jun 12, 2022 by Kody KesterWant $1,000 in Annual Dividend Income? Invest in These StocksReliably growing passive income is the ticket to achieving and maintaining financial independence.
Jun 11, 2022 by Kody Kester2 Best Biotech Stocks to Buy Right NowThese two pharma stocks boast 3%-plus dividend yields, double the S&P 500 index's 1.5% dividend yield.
Jun 11, 2022 by Kody Kester2 Top Healthcare Stocks to Buy Right NowThese stocks are major players in different areas of the healthcare sector.
Jun 9, 2022 by Kody Kester3 No-Brainer Warren Buffett Stocks to Buy Right NowThese stocks can be found within Berkshire Hathaway's massive investment portfolio.
Jun 9, 2022 by Kody Kester2 Dividend Stocks That Will Pay You for LifeThese two stocks pay market-beating dividends to their shareholders.
Jun 8, 2022 by Kody KesterIf You Like Dividends, You Should Love These 3 StocksEach stock yields at least twice the S&P 500 index's 1.5%.
Jun 8, 2022 by Kody Kester2 Dividend Stocks That Will Pay You ForeverThese two Dividend Kings can keep paying a steadily growing stream of passive income for many more years.
Jun 7, 2022 by Kody KesterHere's What This Drug News Could Mean for AbbVie's ShareholdersAbbVie recently shared encouraging clinical trial results for patients taking Rinvoq to treat Crohn's disease.
Jun 6, 2022 by Kody Kester100 Billion Reasons to Like This Dominant Healthcare StockThis mega-cap stock will become the first in the pharmaceutical industry to reach a major sales milestone.
Jun 4, 2022 by Kody Kester2 Top Dividend Kings to Buy for the Long HaulThese two healthcare stocks have delivered ever higher dividends to their shareholders for decades.
Jun 3, 2022 by Kody Kester3 Reasons to Buy This Blue-Chip Stock2022 has been characterized by a paradigm shift from growth stocks to dividend stocks.
Jun 3, 2022 by Kody KesterDown 58% From Its High, Is This Growth Stock a Buy?This pet health insurer has been beaten down largely by the market downturn.
Jun 3, 2022 by Kody KesterIs This Dividend Stock a Buy for Income Investors?There has been a significant rotation from growth stocks into value stocks this year.
Jun 1, 2022 by Kody Kester3 Reasons to Buy This Recession-Proof Dividend StockThis soon-to-be Dividend King offers a safe, market-beating 2.7% dividend yield.
Jun 1, 2022 by Kody KesterWhy This Dominant Fintech Stock Is a BuyThe payments industry has incredible growth potential, and Visa is positioned to capitalize.
